Ivy Blog

Carol Stevens, who faced a glioblastoma recurrence just six months after standard treatment, found new hope in a clinical trial at the Ivy Brain Tumor Center. With a tailored approach that utilized an experimental drug specific to her tumor’s genetics, Carol experienced significant progress, underscoring the trial’s personalized and innovative strategy. Her story highlights the crucial role of clinical trials in providing options where standard treatments fall short. Read her full story!

Discover how COVID-19 has affected brain tumor research in this article from Ivy Brain Tumor Center. Learn about the challenges and potential solutions.